Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
11 tulemused
Biologically active linderazulene terpenes
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention relates to organic compounds and compositions which have useful therapeutic properties. More particularly, the invention concerns novel linderazulene terpene compounds having anti-proliferative and antitumor activities, pharmaceutical compositions comprising
Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
Treatment of human cancer is an area of clinical medicine which remains fraught with complications and which often presents an array of suboptimal treatment choices. For example, prostate cancer, which is the most common cancer in men and the second leading cause of
Substituted-acyclic terpene compound
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE ART
The present invention relates to novel substituted-acyclic terpene compounds. More particularly, the present invention is directed to substituted-acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and
Substituted-acyclic terpene compound
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE ART
The present invention relates to novel substituted-acyclic terpene compounds. More particularly, the present invention is directed to substituted-acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and
Substituted-acyclic terpene compound
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE ART
The present invention relates to novel substituted-acyclic terpene compounds. More particularly, the present invention is directed to substituted-acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and
Substituted-acyclic terpene compound
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE ART
The present invention relates to novel substituted-acyclic terpene compounds. More particularly, the present invention is directed to substituted-acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and
Acyclic terpene compound
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE ART
The present invention relates to novel acyclic terpene compounds. More particularly, the present invention is directed to substituted-acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and anti-tumor
5-fluorouracil derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage entry of International Patent Application No. PCT/EP2013/069981 having a filing date of Sep. 25, 2013, which claims priority to and the benefit of European Patent Application No. 12186564.6 filed in the European Patent
Topical compositions and methods for treating pain
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
II. FIELD OF THE INVENTION
The present invention is directed to a topical composition for treating pain in mammals. Specifically, the present invention comprises a safe and effective amount of acetone, a salicylate-based compound, an emollient and one or more compounds which can function as an
Nanoparticles, composed of sterol and saponin from Quillaja saponaria Molina for use in pharmaceutical compositions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATION
The present application is the U.S. national stage of International Application PCT/SE2014/050380, filed Mar. 31, 2014, which international application was published on Oct. 9, 2014, as International Publication No, WO2014/163558. The International Application
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is in the field of adjuvants and immunostimulating agents. More particularly, the invention pertains to vaccines and immunostimulating compositions that include saponin-lipophile conjugate adjuvants.
2. Related Art
Saponins
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
